All News

Oxybutynin may speed cognitive decline in elderly patients, but is still prescribed.

New technique determines whether cells have been exposed to a cancer-causing toxin.

Patients with diabetes who preferred nighttime were more likely to experience depression symptoms.

Employing proteogenomics helps identifies therapeutic targets in breast cancer.

Forty-seven percent of patients with heart disease did not receive a cholesterol check within the past year.

Nearly 70% of patients with HIV take dietary supplements with their antiretroviral therapy.

Valbenazine (Ingrezza) is a selective vesicular monamine transporter 2 inhibitor approved for tardive dyskinesia.

An epidemiological study of nearly half a million Chinese adults found an association between higher fresh fruit intake and lower risk of diabetes and related complications.

Now, the Pediatric Pharmacy Advocacy Group (PPAG) has joined ACIP in issuing recommendations for HPV vaccination.

Program simulates the physiology of the human body to provide a response model to diseases, medications, and chemicals.

Organs-on-Chips will be used to assess the safety of food, supplements, and cosmetics.

Women given vitamin D3 and calcium supplements had a 30% lower risk of cancer.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

A developmental live-attenuated Zika vaccine showed complete protection from the virus in mice after a single vaccination dose, according to new research published in Nature Medicine.1

Many patients who have HIV use complementary and alternative medicine (CAM) to help handle their health issues.

The final policies are similar to those proposed in February, but underwent changes that were discussed during the public comment period.

The FDA has approved valbenazine (Ingrezza, Neurocrine Biosciences Inc.) capsules, the first drug approved to treat adults with tardive dyskinesia.

Attendees at the 2017 Asembia Specialty Pharmacy Summit will feature a robust lineup of sessions to obtain pharmacy CE credits.

Determining the composition of HIV’s glycoprotein can help fight the virus.

Legislation would allow community pharmacies to participate in Part D networks if they accept regulations and conditions that other in-network pharmacies operate within.

Sen Ron Wyden (D-OR) introduced the C-THRU Act to regulate pharmacy benefit managers.

HR 1939 would allow community pharmacies to participate in Part D plans.

Long-term multivitamin use not found to reduce the risk of cardiovascular events or mortality.

Selective androgen receptor degraders show promise as treatment for castration-resistant prostate cancer.

Spanish researchers have documented the first example of tigecycline-resistant bacteria adapted to living on companion animals through a study that analyzed bacteria isolated from dogs at a veterinary hospital.

Under the ruling, Biogen secured Tecfidera exclusivity through 2028.

Top news of the day from across the health care landscape.

Thirty-one percent of NIH grants have been cited in biomedical patents.

Findings may explain why some patients with cancer respond to immunotherapy while others do not.